Bibliografia UJ CM

1/7
Anthony R. Mato, Jennifer A. Woyach, Jennifer R. Brown, Paolo Ghia, Krish Patel, Toby A. Eyre, Talha Munir, Ewa Lech-Maranda, Nicole Lamanna, Constantine S. Tam, Nirav N. Shah, Catherine C. Coombs, Chaitra S. Ujjani, Bita Fakhri, Chan Y. Cheah, Manish R. Patel, Alvaro J. Alencar, Jonathon B. Cohen, James N. Gerson, Ian W. Flinn, Shuo Ma, Deepa Jagadeesh, Joanna M. Rhodes, Francisco Hernandez-Ilizalitur, Pier L. Zinzani, John F. Seymour, Minna Balbas, Binoj Nair, Paolo Abada, Chunxiao Wang, Amy S. Ruppert, Denise Wang, Donald E. Tsai, William G. Wierda, Wojciech Jurczak.
Pirtobrutinib after a covalent BTK inhibitor in chronic lymphocytic leukemia
New England Journal of Medicine
2023 : Vol. 389, nr 1, s. 33-44, il., bibliogr. 32 poz., abstr.
Autor korespondencyjny: Jennifer A. Woyach
p-ISSN: 0028-4793
AZ
ORG
AIF
IF: 158.500
Adres url:
Streszczenie w PubMed:
2/7
Peter Hillmen, Barbara Eichhorst, Jennifer R. Brown, Nicole Lamanna, Susan M. O'Brien, Constantine S. Tam, Lugui Qiu, Maciej Kazmierczak, Keshu Zhou, Martin Simkovic, Jiri Mayer, Amanda Gillespie-Twardy, Mazyar Shadman, Alessandra Ferrajoli, Peter S. Ganly, Robert Weinkove, Sebastian Grosicki, Andrzej Mital, Tadeusz Robak, Anders Osterborg, Habte A. Yimer, Tommi Salmi, Meng Ji, Jessica Yecies, Adam Idoine, Kenneth Wu, Jane Huang, Wojciech Jurczak.
Zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma : interim analysis of a randomized phase III trial.
Journal of Clinical Oncology
2023 : Vol. 41, nr 5, s. 1035-1045, il., bibliogr. 22 poz.
Autor korespondencyjny: Peter Hillmen
Online First 2022-11-17
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
AZ
ORG
AIF
IF: 45.300
Adres url:
Streszczenie w PubMed:
3/7
Jennifer R. Brown, John C. Byrd, Paolo Ghia, Jeff P. Sharman, Peter Hillmen, Deborah M. Stephens, Clare Sun, Wojciech Jurczak, John M. Pagel, Alessandra Ferrajoli, Priti Patel, Lin Tao, Nataliya Kuptsova-Clarkson, Javid Moslehi, Richard R. Furman.
Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy : pooled analysis of 762 patients
Haematologica
2022 : Vol. 107, nr 6, s. 1335-1346, il., bibliogr. 52 poz., abstr.
Autor korespondencyjny: Jennifer R. Brown
Open Access Creative Commons Attribution License CC-BY-NC 4.0
p-ISSN: 0390-6078
AZ
ORG
AIF
IF: 10.100
Adres url:
Streszczenie w PubMed:
4/7
Constantine S. Tam, Jennifer R. Brown, Brad S. Kah, Paolo Ghia, Giannopoulo Giannopoulos, Wojciech Jurczak, Martin imkovič, Mazyar Shadman, Anders Österborg, Luca Laurenti, Patricia Walker, Stephen Opat, Henry Chan, Hanna Ciepluch, Richard Greil, Monica Tani, Marek Trneny, Danielle M. Brander, Ian W. Flinn, Sebastian Grosicki, Emma Verner, Alessandra Tedeschi, Jianyong Li, Tian Tian, Lei Zhou, Carol Marimpietri, Jason C. Paik, Aileen Cohe, Jane Huang, Tadeusz Robak, Peter Hillmen.
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA) : a randomised, controlled, phase 3 trial.
Lancet. Oncology
2022 : Vol. 23, nr 8, s. 1031-1043, il., bibliogr. 31 poz., sum.
Autor korespondencyjny: Tadeusz Robak, Peter Hillmen.
p-ISSN: 1470-2045
e-ISSN: 1474-5488
AZ
ORG
AIF
IF: 51.100
Adres url:
Streszczenie w PubMed:
5/7
Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak, Chan Y. Cheah, John M. Pagel, Jennifer A. Woyach, Bita Fakhri, Toby A. Eyre, Nicole Lamanna, Manish R. Patel, Alvaro Alencar, Ewa Lech-Maranda, William G. Wierda, Catherine C. Coombs, James N. Gerson, Paolo Ghia, Steven Le Gouill, David John Lewis, Suchitra Sundaram, Jonathon B. Cohen, Ian W. Flinn, Constantine S. Tam, Minal A. Barve, Bryone Kuss, Justin Taylor, Omar Abdel-Wahab, Stephen J. Schuster, M. Lia Palomba, Katharine L. Lewis, Lindsey E. Roeker, Matthew S. Davids, Xuan Ni Tan, Timothy S. Fenske, Johan Wallin, Donald E. Tsai, Nora C. Ku, Edward Zhu, Jessica Chen, Ming Yin, Binoj Nair, Kevin Ebata, Narasimha Marella, Jennifer R. Brown, Michael Wang.
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN) : a phase 1/2 study.
Lancet
2021 : Vol. 397, nr 10277, s. 892-901, il., bibliogr. 30 poz., sum.
Autor korespondencyjny: Anthony R. Mato.
p-ISSN: 0140-6736
AZ
ORG
AIF
IF: 202.731
Adres url:
Streszczenie w PubMed:
6/7
Richard R. Furman, John C. Byrd, Roger G. Owen, Susan M. O'Brien, Jennifer R. Brown, Peter Hillmen, Deborah M. Stephens, Nataliya Chernyukhin, Tamara Lezhava, Ahmed M. Hamdy, Raquel Izumi, Priti Patel, Marshall Baek, Beth Christian, Martin J. S. Dyer, Matthew J. Streetly, Clare Sun, Simon Rule, Michael Wang, Paolo Ghia, Wojciech Jurczak, John M. Pagel, Jeff P. Sharman.
Pooled analysis of safety data from clinical trials evaluating acalabrutinib monotherapy in mature B-cell malignancies.
Leukemia
2021 : Vol. 35, nr 11, s. 3201-3211, il., bibliogr. 41 poz., abstr.
Autor korespondencyjny: Richard R. Furman.
p-ISSN: 0887-6924
e-ISSN: 1476-5551
AZ
ORG
AIF
IF: 12.897
Adres url:
Streszczenie w PubMed:
7/7
Andrew D. Zelenetz, Jacqueline C. Barrientos, Jennifer R. Brown, Bertrand Coiffier, Julio Delgado, Miklós Egyed, Paolo Ghia, Árpad Illes, Wojciech Jurczak, Paula Marlton, Marco Montillo, Franck Morschhauser, Alexander S. Pristupa, Tadeusz Robak, Jeff P. Sharman, David Simpson, Lukas Smolej, Eugen Tausch, Adeboye H. Adewoye, Lyndah K. Dreiling, Yeonhee Kim, Stephan Stilgenbauer, Peter Hillmen.
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet. Oncology
2017 : Vol. 18, nr 3, s. 297-311, il., bibliogr. 22 poz., sum.
Autor korespondencyjny: Andrew D. Zelenetz.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 36.418
Adres url:
Streszczenie w PubMed:
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ